Search

everythinglearnresearchcommunity

for

Search:↓

Hormonal treatments can help with hair loss, acne, and excess hair growth, but it takes 3-6 months to see results and patients should know the possible side effects.

Ovarian steroid cell tumors should be considered in adults with hirsutism and high testosterone, with surgery as the main treatment.

The document concludes that accurate diagnosis of male and female gonadal disorders is crucial for effective treatment and better patient outcomes.

Hirsutism is often caused by high male hormone levels and can be treated with lifestyle changes and medications.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

Testosterone therapy can help with androgen deficiency in women but should be used with caution and monitoring due to potential risks.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.

Hirsutism is when women have too much hair growth, often due to a bit more androgen hormones and sensitive skin.

Gender-affirming care for youth remained essential during the COVID-19 pandemic, with telemedicine playing a key role.

Gender-affirming therapy can cause skin issues like acne and hair loss in transgender adolescents, and more research is needed on its dermatological effects.

The guidelines help doctors diagnose and treat hormone-related disorders in women.

Androgens are important for female fertility and could help in IVF treatment, but also play a role in causing PCOS.

Finasteride, a hair loss drug, may cause long-term sexual side effects due to changes in hormone receptor levels.

The document says that hirsutism in women usually needs hair removal and hormone treatment to manage symptoms and improve well-being.

The document concludes that more multidisciplinary research is needed to understand and treat PCOS, a condition that significantly affects women's health and quality of life.

Flutamide combined with a low-dose birth control pill effectively reduces excessive hair growth in women with polycystic ovarian disease.

High androgen levels in postmenopausal women may suggest an ovarian tumor, and removing it can improve heart and metabolic health.

Hormone therapy improves mental well-being in transgender individuals but requires ongoing health monitoring.

The conclusion is that thorough investigation of hypertension and hormonal dysfunctions is important, and there may be a link between these conditions and cancer.

Higher testosterone and DHT levels are linked to hair loss in men, but not to prostate cancer risk.

The document concluded that more research is needed to understand how estrogen affects the enzyme involved in hirsutism development.

Understanding Polycystic Ovary Syndrome (PCOS) and its causes can lead to effective treatments.

Certain medications, especially Paroxetine, Tamsulosin, and Finasteride, are linked to ejaculatory disorders.

Statins may help treat PCOS by lowering androgen levels and improving cholesterol.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

Effective hair loss treatment in women requires correct diagnosis and can include medications like minoxidil, antiandrogens, and treatments for underlying conditions like PCOS.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

The document concludes that proper diagnosis and a multidisciplinary approach are crucial for managing Congenital Adrenal Hyperplasia effectively.